Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

New and superior adrenal scanning agent, NP-59

Journal Article · · J. Nucl. Med., v. 16, no. 11, pp. 1038-1042
OSTI ID:4160305

The first synthesis of $sup 131$I-19-iodocholesterol had a 10 to 25 percent radiochemical impurity that was not iodide ion. This impurity has been identified as 6$beta$$-$$sup 131$I-iodomethyl-19-nor cholest-5(10)-en-3$beta$-ol (NP-59) and has been synthesized. Tissue distribution studies with $sup 131$I-NP- 59 in rats and dogs revealed a higher adrenal uptake and adrenal-to-tissue ratios compared to $sup 131$I 19-iodocholesterol, probably less in vivo deiodination, and superior adrenal images. A high uptake was seen in the adrenal medulla in addition to that in the cortex. Iodine-131-NP-59 is being evaluated for the early detection of adrenal--cortical disorders and as a potential scanning agent for detecting structural abnormalities of the adrenal medulla. (auth)

Research Organization:
Univ. of Michigan, Ann Arbor
NSA Number:
NSA-33-007630
OSTI ID:
4160305
Journal Information:
J. Nucl. Med., v. 16, no. 11, pp. 1038-1042, Journal Name: J. Nucl. Med., v. 16, no. 11, pp. 1038-1042; ISSN JNMEA
Country of Publication:
United States
Language:
English